| Schedule of Franchisor Disclosure |
The following table summarizes the number of clinics in operation under franchise agreements and as company-owned or managed clinics for the three and six months ended June 30, 2021 and 2020:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
June 30, |
|
Six Months Ended
June 30, |
| Franchised clinics: |
2021 |
|
2020 |
|
2021 |
|
2020 |
| Clinics open at beginning of period |
527 |
|
|
469 |
|
|
515 |
|
|
453 |
|
| Opened during the period |
36 |
|
|
12 |
|
|
48 |
|
|
28 |
|
| Sold during the period |
(8) |
|
|
— |
|
|
(8) |
|
|
— |
|
| Closed during the period |
— |
|
|
(4) |
|
|
— |
|
|
(4) |
|
| Clinics in operation at the end of the period |
555 |
|
|
477 |
|
|
555 |
|
|
477 |
|
|
|
|
|
|
|
|
|
|
Three Months Ended
June 30, |
|
Six Months Ended
June 30, |
| Company-owned or managed clinics: |
2021 |
|
2020 |
|
2021 |
|
2020 |
| Clinics open at beginning of period |
65 |
|
|
61 |
|
|
64 |
|
|
60 |
|
| Opened during the period |
5 |
|
|
1 |
|
|
6 |
|
|
2 |
|
| Acquired during the period |
8 |
|
|
— |
|
|
8 |
|
|
— |
|
| Closed during the period |
— |
|
|
— |
|
|
— |
|
|
— |
|
| Clinics in operation at the end of the period |
78 |
|
|
62 |
|
|
78 |
|
|
62 |
|
|
|
|
|
|
|
|
|
| Total clinics in operation at the end of the period |
633 |
|
|
539 |
|
|
633 |
|
|
539 |
|
|
|
|
|
|
|
|
|
| Clinic licenses sold but not yet developed |
247 |
|
|
169 |
|
|
247 |
|
|
169 |
|
| Executed letters of intent for future clinic licenses |
35 |
|
|
40 |
|
|
35 |
|
|
40 |
|
|
| Schedule of Earnings (Loss) per Common Share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
June 30, |
|
Six Months Ended
June 30, |
|
2021 |
|
2020 |
|
2021 |
|
2020 |
| Net Income |
$ |
2,683,962 |
|
|
$ |
115,585 |
|
|
$ |
4,998,657 |
|
|
$ |
930,532 |
|
|
|
|
|
|
|
|
|
| Weighted average common shares outstanding - basic |
14,290,697 |
|
|
13,980,984 |
|
|
14,234,929 |
|
|
13,935,829 |
|
| Effect of dilutive securities: |
|
|
|
|
|
|
|
| Unvested restricted stock and stock options |
636,754 |
|
|
510,655 |
|
|
666,934 |
|
|
551,254 |
|
| Weighted average common shares outstanding - diluted |
14,927,451 |
|
|
14,491,639 |
|
|
14,901,863 |
|
|
14,487,083 |
|
|
|
|
|
|
|
|
|
| Basic earnings per share |
$ |
0.19 |
|
|
$ |
0.01 |
|
|
$ |
0.35 |
|
|
$ |
0.07 |
|
| Diluted earnings per share |
$ |
0.18 |
|
|
$ |
0.01 |
|
|
$ |
0.34 |
|
|
$ |
0.06 |
|
Potentially dilutive securities excluded from the calculation of diluted net income per common share as the effect would be anti-dilutive were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
June 30, |
|
Six Months Ended
June 30, |
| Weighted average potentially dilutive securities: |
2021 |
|
2020 |
|
2021 |
|
2020 |
| Unvested restricted stock |
1,576 |
|
|
18,557 |
|
|
792 |
|
|
11,318 |
|
| Stock options |
45,825 |
|
|
174,213 |
|
|
30,399 |
|
|
137,952 |
|
|